This protocol is judged by an institutional review board, an independent group that evaluations any scientific trials involving people. If a research consists of a Agenda I drug, when the board approves the protocol as ethical, the researchers should make an application for an investigational new drug (IND) variety from your FDA.“It’s imperativ